Literature DB >> 13147591

Further evaluation of hydralazine in treatment of hypertensive disease.

R D TAYLOR, A C CORCORAN, H P DUSTAN, I H PAGE.   

Abstract

Entities:  

Keywords:  HYPERTENSION/therapy; SYMPATHOLYTICS/therapeutic use

Mesh：

Substances：

Year:  1954        PMID： 13147591     DOI： 10.1001/archinte.1954.00240290063007

Source DB:  PubMed          Journal:  AMA Arch Intern Med        ISSN： 0888-2479


× No keyword cloud information.
  5 in total

1.  Significant clinical variations in hypertension.

Authors:  M J MOSELY
Journal:  J Natl Med Assoc       Date:  1955-07       Impact factor: 1.798

2.  A clinical evaluation of antihypertensive drugs.

Authors:  I H PAGE
Journal:  Bull N Y Acad Med       Date:  1957-04

3.  Hypertensive vascular disease as a consequence of increased arterial pressure; quantitative study in rats with hydralazine-treated renal hypertension.

Authors:  G M MASSON; L J McCORMACK; H P DUSTAN; A C CORCORAN
Journal:  Am J Pathol       Date:  1958 Sep-Oct       Impact factor: 4.307

4.  Drug treatment of hypertension.

Authors:  E G MCQUEEN; F H SMIRK
Journal:  Postgrad Med J       Date:  1956-02       Impact factor: 2.401

5.  Ambulatory pressure monitoring in the assessment of antihypertensive therapy.

Authors:  A J Coats; J Conway; V K Somers; J E Isea; P Sleight
Journal:  Cardiovasc Drugs Ther       Date:  1989-06       Impact factor: 3.727
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.